3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
2
INDUSTRY
2
Study Type
Observational
2
Sponsor
Cancer Type
Classical hematology
2
Conditions
Venous Thromboembolism
2
Neoplasms
2
Prostatic Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Hot Flashes
1
Embolism
1
Cushing Syndrome
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Non-small Cell Lung Cancer
1
Interventions
apixaban
5
Rivaroxaban
5
Dalteparin
4
Enoxaparin
3
edoxaban
2
abelacimab
2
Tinzaparin
2
MAA868
2
Heparin, Low-Molecular-Weight
2
Dabigatran
2
isoquercitrin
1
calcium heparin
1
betrixaban
1
bemiparin
1
Warfarin
1
Heparin
1
Gemcitabine
1
Fondaparinux
1
AVE 5026
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Venous Thromboembolism
×
Dabigatran
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled
NCT03965741
2021-11-30
PRACTISE
Bayer
Completed
97,765 enrolled